Heparin-binding EGF-like growth factor in human serum. Association with high blood cholesterol and heart hypertrophy

Growth Factors

Volumn 28, Issue 2, 2010, Pages 98-103

  Sánchez Vizcaíno, Elena ^a,b   Vehí, Cristina ^b   Campreciós, Gens ^a   Morcillo, César ^b   Soley, Maria ^a   Ramírez, Ignasi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Centro Internacional de Medicina Avanzada   (Spain)

Author keywords

Arterial blood pressure; Body mass index; Heart hypertrophy

Indexed keywords

CHOLESTEROL; EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM;

ADULT; CARDIOMEGALY; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; UP-REGULATION;

ANIMALIA;

EID: 77949461859     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903443030     Document Type: Article

References (27)

1. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, HoriM, Higashiyama S. 2002. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy. Nat Med 8:35-40.
2. Chai TC, Zhang CO, Shoenfelt JL, Johnson HW, Warren JW, Keay S. 2000. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J Urol 163:1440-1444.
3. Evangelista-Masip A, Alonso-Gómez AM, Martín-Duran R, Moreno-Yagüela M, Oliver-Ruiz JM, Rodríguez-Pardial L, Tobaruela A. 2000. Clinical practice guidelines of the Spanish Society of Cardiology on echocardiography. Rev Esp Cardiol 53: 663-683.
4. Fischer OM, Hart S, Gschwind A, Ullrich A. 2003. EGFR signal transactivation in cancer cells. Biochem Soc Trans 31(Part 6): 1203-1208.
5. Grau M, Rodríguez C, Soley M, Ramírez I. 1994. Relationship between epidermal growth factor in mouse submandibular glands, plasma, and bile: Effects of catecholamines and fasting. Endocrinology 135:1854-1862.
6. Harris RC, Chung E, Coffey RJ. 2003. EGF receptor ligands. Exp Cell Res 284:2-13.
7. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. 1991. A heparin-binding growth factor secreted by macrophagelike cells that is related to EGF. Science 251:936-939.
8. Homma T, Sakai M, Cheng HF, Yasuda T, Coffey RJ, Jr., Harris RC. 1995. Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest 96:1018-1025.
9. Iwamoto R, Mekada E. 2006. ErbB and HB-EGF signaling in heart development and function. Cell Struct Funct 31:1-14.
10. Keay S, Zhang CO, Kagen DI, Hise MK, Jacobs SC, Hebel JR, Gordon D, Whitmore K, Bodison S, Warren JW. 1997. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol 158: 1983-1988.
11. Keay S, Kleinberg M, Zhang CO, Hise MK, Warren JW. 2000. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol 164:2112-2118.
12. Kiso S, Kawata S, Tamura S, Inui Y, Yoshida Y, Sawai Y, Umeki S, Ito N, Yamada A, Miyagawa JI, Higashiyama S, Iwawaki T, Saito M, Taniguchi N, Matsuzawa Y, Kohno K. 2003. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 124: 701-707.
13. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M. 1993. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90:3889-3893.
14. Matsumoto S, Kishida K, Shimomura I, Maeda N, Nagaretani H, Matsuda M, Nishizawa H, Kihara S, Funahashi T, Matsuzawa Y. 2002. Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochem Biophys Res Commun 292: 781-786.
15. Mattila AL, Viinikka L, Saario I, Perheentupa J. 1988. Human epidermal growth factor: Renal production and absence from plasma. Regul Pept 23:89-93.
16. Miyagawa J, Higashiyama S, Kawata S, Inui Y, Tamura S, Yamamoto K, Nishida M, Nakamura T, Yamashita S, Matsuzawa Y, Taniguchi N. 1995. Localization of heparinbinding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest 95: 404-411.
17. Nakata A, Miyagawa J, Yamashita S, Nishida M, Tamura R, Yamamori K, Nakamura T, Nozaki S, Kameda-Takemura K, Kawata S, Taniguchi N, Higashiyama S, Matsuzawa Y. 1996. Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HBEGF in the formation of coronary atherosclerosis. Circulation 94:2778-2786.
18. Pareja M, Sánchez O, Lorita J, Soley M, Ramírez I. 2003. Activated epidermal growth factor receptor (ErbB1) protects the heart against stress-induced injury in mice. Am J Physiol Regul Integr Comp Physiol 285:R455-R462.
19. Peoples GE, Blotnick S, Takahashi K, Freeman MR, Klagsbrun M, Eberlein TJ. 1995. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: A potential pathologic role. Proc Natl Acad Sci USA 92: 6547-6551.
20. Pesonen K, Viinikka L, Myllyla G, Kiuru J, Perheentupa J. 1989. Characterization of material with epidermal growth factor immunoreactivity in human serum and platelets. J Clin Endocrinol Metab 68:486-491.
21. Pillai SB, Hinman CE, Luquette MH, Nowicki PT, Besner GE. 1999. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury. J Surg Res 87:225-231.
22. Raab G, Klagsbrun M. 1997. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333:F179-F199.
23. Sanderson MP, Dempsey PJ, Dunbar AJ. 2006. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Growth Factors 24:121-136.
24. Ushikoshi H, Takahashi T, Chen X, Khai NC, Esaki M, Goto K, Takemura G, Maruyama R, Minatoguchi S, Fujiwara T, Nagano S, Yuge K, Kawai T, Murofushi Y, Fujiwara H, Kosai K. 2005. Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes. Lab Invest 85:862-873.
25. Yamada A, Kawata S, Tamura S, Kiso S, Higashiyama S, Umeshita K, Sakon M, Taniguchi N, Monden M, Matsuzawa Y. 1998. Plasma heparin-binding EGF-like growth factor levels in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Biochem Biophys Res Commun 246:783-787.
26. Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137.
27. Zhang CO, Li ZL, Kong CZ. 2005. APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis. BMC Urol 5:7.